Home > Insider Trading > Filing (0001104659-23-122840)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1017491	Seelos Therapeutics Inc.	SEEL	Pharmaceutical Preparations (2834)	870449967

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1757892	Raj Mehra	C/O Seelos Therapeutics, Inc. 300 Park Avenue, 2Nd Floor New York NY 10022	See Remarks	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-12-01	75,757	$1.32	185,142	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrant (right to buy)	Acquisiton	2023-12-01	75,757	$0.00	75,757	$1.32

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
75,757	2023-12-01	2028-12-01	No	4	P	Direct

Footnotes

Each share of common stock was purchased together with an accompanying warrant to purchase one share of common stock in an underwritten public offering at a combined offering price of $1.32 per share of common stock and accompanying warrant.
Effective on November 28, 2023, the Issuer conducted a reverse stock split at a ratio of 1-for-30 (the "Reverse Split"). The number of shares reported herein reflects the number of shares after the Reverse Split.